FindTrial
Sign In

To assess the genetic prevalence of NASH related liver cirrhosis in association with matraja bhava (Maternal factor)- A Cross-sectional study

Assessment of genetic prevalence of NASH related liver cirrhosis in association with matraja bhava (Maternal factor)- A Cross-sectional study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/05/053083
Enrollment
60
Registered
2023-05-23
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K746- Other and unspecified cirrhosis ofliver

Interventions

None listed

Sponsors

CH BRAHM PRAKASH AYURVEDA CHARAK SANSTHAN
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed patients of NASH Liver cirrhosis

Exclusion criteria

Exclusion criteria: 1. History of Alcohol abuse 2. Pregnant women 3. Participants on medications that causes liver damage. 4. Active or previous infection with hepatitis B and C

Design outcomes

Primary

MeasureTime frame
To Assess the genetic prevalence of NASH related liver cirrhosisTimepoint: 8 Weeks—

Secondary

MeasureTime frame
Establishment of association between matraja bhava and Nash related liver cirrhosisTimepoint: 8 Weeks—

Countries

India

Contacts

Public ContactDR JASMEEN KAUR

Ch. Brahm Prakash Ayurved Charak Sansthan

jagjas3121@gmail.com9899185481

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026